Department of Urology, China and Japan Union Hospital of Jilin University, Changchun, China.
J Endourol. 2013 Sep;27(9):1120-5. doi: 10.1089/end.2012.0535. Epub 2013 May 30.
Abstract To determine whether treatment of patients with large (>15 mm) impacted upper ureteral stones depended on stone location, we prospectively evaluated the therapeutic outcomes, complications, safety, and effectiveness of percutaneous nephrolithotomy (PCNL) and ureteroscopic lithotomy (URSL) in patients with stones higher and lower than the upper border of the fourth lumbar vertebra. Of the 174 patients analyzed, 83 (47.7%) underwent PCNL and 91 (52.3%) underwent URSL; all patients were followed up 1 month later and every 6 months for 18 months. Mean operation time (108.76±19.36 vs. 63.56±16.38 minutes, p<0.05) and postoperative hospital stay (2.49±1.23 vs. 5.36±1.98 days, p<0.05) were significantly longer in the PCNL than in the URSL group. The overall stone-free rates after 1 month were 96.4% and 75.8%, respectively, differing significantly for stones higher (97.8% vs. 57.5%, p<0.05) but not lower (94.7% vs. 90.2%) than the upper border of the fourth lumbar vertebra. The stone-retropulsion rate of URSL differed significantly for stones higher and lower than the upper border of the 4th lumbar vertebra (47.5% vs. 9.8%, p<0.05). Postprocedural complication rates were comparable in the URSL and PCNL groups, although the rate of auxiliary or salvage procedures was higher in the URSL group. The efficiency quotients (EQ) for PCNL and URSL were 0.93 and 0.59, respectively, with EQs in the URSL group differing significantly for stones higher and lower than the upper border of the fourth lumbar vertebra (0.40 vs. 0.82, p<0.05). Our findings indicate that treatment of impacted upper ureteral stones is dependent on stone location relative to the upper border of the fourth lumbar vertebra. URSL is unsuitable for stones at a higher location, whereas URSL and PCNL were equally effective for stones at a lower location.
为了确定治疗大于 15mm 的大体积嵌顿性上段输尿管结石是否依赖结石位置,我们前瞻性评估了 PCNL 和 URSL 治疗第四腰椎上缘以上和以下结石的治疗效果、并发症、安全性和有效性。在分析的 174 例患者中,83 例(47.7%)接受了 PCNL,91 例(52.3%)接受了 URSL;所有患者在 1 个月后和之后的 18 个月每 6 个月进行随访。PCNL 组的平均手术时间(108.76±19.36 分钟 vs. 63.56±16.38 分钟,p<0.05)和术后住院时间(2.49±1.23 天 vs. 5.36±1.98 天,p<0.05)明显长于 URSL 组。1 个月后,结石完全清除率分别为 96.4%和 75.8%,第四腰椎上缘以上的结石完全清除率(97.8% vs. 57.5%,p<0.05)显著高于第四腰椎上缘以下的结石完全清除率(94.7% vs. 90.2%)。URSL 治疗第四腰椎上缘以上和以下结石的结石后反流率差异有统计学意义(47.5% vs. 9.8%,p<0.05)。URSL 和 PCNL 组的术后并发症发生率相当,尽管 URSL 组的辅助或挽救性手术率较高。PCNL 和 URSL 的效率系数(EQ)分别为 0.93 和 0.59,URSL 组第四腰椎上缘以上和以下结石的 EQ 差异有统计学意义(0.40 vs. 0.82,p<0.05)。我们的研究结果表明,嵌顿性上段输尿管结石的治疗取决于结石相对于第四腰椎上缘的位置。URSL 不适合治疗位置较高的结石,而 URSL 和 PCNL 对位置较低的结石均有效。